Endogenous factors controlling sleep

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Current Anaesthesia & Critical Care

• Publication date

  2002-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1054/CACC.2002.0377
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Humoral transmission of sleep and wakefulness

  2004cited by this paper
• Neurohumoral ausgelöste Schlafzustände an Tieren mit gekreuztem Kreislauf unter der Kontrolle von EEG-Ableitungen

  2004cited by this paper
• Anesthetic-like Interaction of the Sleep-inducing Lipid Oleamide with Voltage-gated Sodium Channels in Mammalian Brain

  2001cited by this paper
• Linoleamide, a brain lipid that induces sleep, increases cytosolic Ca2+ levels in MDCK renal tubular cells.

  2001cited by this paper
• L-364,718, a cholecystokinin-A receptor antagonist, suppresses feeding-induced sleep in rats.

  2001cited by this paper
• Anandamide-induced sleep is blocked by SR141716A, a CB1 receptor antagonist and by U73122, a phospholipase C inhibitor

  2001cited by this paper
• Studies on the Sedative and Hypnotic Effects of Oleamide in Mice

  1999cited by this paper
• The Endogenous Lipid Oleamide Activates Serotonin 5‐HT7 Neurons in Mouse Thalamus and Hypothalamus

  1999cited by this paper
• Long‐term enhancement of REM sleep by the pituitary adenylyl cyclase‐activating polypeptide (PACAP) in the pontine reticular formation of the rat

  1999cited by this paper
• The palmitoylethanolamide and oleamide enigmas : are these two fatty acid amides cannabimimetic?

  1999cited by this paper
• Rapid eye movement sleep induction by vasoactive intestinal peptide infused into the oral pontine tegmentum of the rat may involve muscarinic receptors.

  1999cited by this paper
• Characterization of the hypnotic properties of oleamide.

  1999cited by this paper
• Opioid detoxification with delta sleep-inducing peptide: results of an open clinical trial.

  1998cited by this paper
• Anandamide modulates sleep and memory in rats.

  1998cited by this paper
• Structural requirements for 5-HT2A and 5-HT1A serotonin receptor potentiation by the biologically active lipid oleamide.

  1998cited by this paper
• Oleamide potentiates benzodiazepine-sensitive gamma-aminobutyric acid receptor activity but does not alter minimum alveolar anesthetic concentration.

  1998cited by this paper
• Effects of a specific CCK-A antagonist, Loxiglumide, on postprandial mood and sleepiness

  1997cited by this paper
• Unique allosteric regulation of 5-hydroxytryptamine receptor-mediated signal transduction by oleamide.

  1997cited by this paper
• The Sleep-inducing Lipid Oleamide Deconvolutes Gap Junction Communication and Calcium Wave Transmission in Glial Cells

  1997cited by this paper
• A hypothesis about the endogenous analogue of general anesthesia.

  1997cited by this paper
• Brain lipids that induce sleep are novel modulators of 5-hydroxytrypamine receptors.

  1996cited by this paper
• VIP decelerates non-REM-REM cycles and modulates hormone secretion during sleep in men.

  1996cited by this paper
• Delta sleep-inducing peptide in normal humans and in patients with sleep apnea and narcolepsy.

  1995cited by this paper
• Is the nucleus raphe dorsalis a target for the peptides possessing hypnogenic properties?

  1994cited by this paper
• Diurnal rhythm of plasma delta-sleep-inducing peptide in humans: evidence for positive correlation with body temperature and negative correlation with rapid eye movement and slow wave sleep.

  1994cited by this paper
• The Role of the GABAA Receptor/Chloride Channel Complex in Anesthesia

  1993cited by this paper
• Effects of delta sleep-inducing peptide on sleep of chronic insomniac patients. A double-blind study.

  1992cited by this paper
• Intraperitoneal injection of cholecystokinin elicits sleep in rabbits.

  1991cited by this paper
• Biology of Sleep Substances

  1989cited by this paper
• Delta-sleep-inducing peptide (DSIP) stimulates the release of immunoreactive Met-enkephalin from rat lower brainstem slices in vitro.

  1989cited by this paper
• Study of delta sleep-inducing peptide efficacy in improving sleep on short-term administration to chronic insomniacs.

  1987cited by this paper
• Structure-activity relationship in the effects of delta-sleep-inducing peptide (DSIP) on rat sleep.

  1986cited by this paper
• Efficacy of DSIP to normalize sleep in middle-aged and elderly chronic insomniacs.

  1986cited by this paper
• Delta-sleep-inducing peptide (DSIP): an update.

  1986cited by this paper
• Therapeutic effects of delta-sleep-inducing peptide (DSIP) in patients with chronic, pronounced pain episodes. A clinical pilot study.

  1984cited by this paper
• Peptidoglycans as promoters of slow-wave sleep. II. Somnogenic and pyrogenic activities of some naturally occurring muramyl peptides; correlations with mass spectrometric structure determination.

  1984cited by this paper
• Effects of DSIP on narcolepsy.

  1984cited by this paper
• DSIP in the treatment of withdrawal syndromes from alcohol and opiates.

  1984cited by this paper
• Radioimmunoassay of delta sleep-inducing peptide using an iodinated p-hydroxyphenylpropionic acid derivative as tracer.

  1983cited by this paper
• [Theoretical conformational analysis of delta-sleep inducing peptide].

  1982cited by this paper
• A naturally occurring delta-EEG enhancing nonapeptide in rabbits

  1977cited by this paper
• Humoral influences of induced sleep and arousal upon electrical brain activity of animals with crossed circulation

  1963cited by this paper

• No citing papers are available for this paper.